Ceftazidime treatment in cystic fibrosis: resistant organisms in sputum and faeces.

Ceftazidime was used as the only intravenous agent for treating lower respiratory tract infections in patients with cystic fibrosis. The risks of inducing beta lactamases and conferring antibiotic resistance are high when monotherapy is used; so the emergence of resistant bacteria was studied prospe...

Volledige beschrijving

Bibliografische gegevens

Gepubliceerd in:	Thorax
Hoofdauteurs:	Dalzell, A M, Sunderland, D, Hart, C A, Heaf, D P
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMJ Publishing Group 1991
Onderwerpen:	Research Article
Online toegang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC463083/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1903896/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.46.4.239
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!